Co-Administration of Chenopodium Album Allergens and CpG Oligodeoxy-nucleotides Effects on Peripheral Blood Mononuclear Cells of Patients with Allergic Rhinitis Treated with Intranasal Corticosteroids

Shokrollah Farrokhi; Tahereh Mousavi; Saba Arshi; Abdolreza Varasteh; Nima Rezaei; Alireza Salekmoghadam

Co-Administration of Chenopodium Album Allergens and CpG Oligodeoxy-nucleotides Effects on Peripheral Blood Mononuclear Cells of Patients with Allergic Rhinitis Treated with Intranasal Corticosteroids

Alireza Salekmoghadam

Abstract

Allergic Rhinitis (AR) is one of the most common chronic diseases in the developed countries. This study was performed to investigate the effect of CpG-ODN in alteration of T-helper (Th)1/Th2 balance of patients with AR treated with intranasal corticosteroids (INCs) and antihistamines. Peripheral blood mononuclear cells (PBMCs) of 20 patients with AR were isolated before and after 45 days therapy.
Cytokine production (IL-4, IL-10, IL-13, IFN-γ) and specific Ch.a IgE in response to CpG co- administration of natural chenopodium album (CpG/Ch.a) or recombinant Ch.a (CpG/rCh.a) allergen were investigated in supernatants.of cultured PBMCs using ELISA Intracellular IL-10 was also assessed in CD4+ cells using flow cytometry. Significant increase in production of IFN-γ and IL-10 and decrease in production of IL-4 were found in supernatants of cultured PBMCs activated with CPG/ch.a and CPG/rch.a. of both CpG/Ch.a and CpG/rCh.a compared to allergens alone, before and after therapy.
After therapy, IFN-γ production with CpG/Ch.a was significantly increased in comparison with before (237 vs. 44 pg/ml, p=0.001). IFN-γ and IL-10 production with CpG/rCh.a was significantly increased after therapy compared to before (407.6 vs. 109 pg/ml, p=0.01 for IFN-γ; 171.7 vs. 52.6 pg/ml, p=0.008 for IL-10), whilst IL-4 was significantly decreased (2.1 vs. 5.8 pg/ml, p=0.02). Intracellular IL-10 expression was also significantly increased in response to either CpG/Ch.a or CpG/rCh.a that showed intracellular assay could be more sensitive than ELISA. Also, treatment with intranasal corticosteroids and antihistamines could enhance this CpG effect, in vitro.

1.Verlato G, Corsico A, Villani S, Cerveri I, Migliore E, Accordini S, et al. Is the prevalence of adult asthma and allergic rhinitis still increasing? Results of an Italian study. J Allergy Clin Immunol 2003; 111(6):1232-38.
2. Fireman P. Cytokines and allergic rhinitis. Allergy Asthma Proc 1996; 17(4):175-78.
3. Mullol J, Valero A, Alobid I, Bartra J, Navarro AM, Chivato T, et al. Allergic Rhinitis and its Impact on Asthma update (ARIA 2008). The perspective from Spain. J Investig Allergol Clin Immunol 2008; 18(5):327-34.
4. Mirsaid Ghazi B, Imamzadehgan R, Aghamohammadi A, Darakhshan Davari R, Rezaei N. Frequency of Allergic Rhinitis in School-age Children (7-18 Years) in Tehran. Iran J Allergy Asthma Immunol 2003; 2(4):181-4.
5. Asai K, Foley SC, Sumi Y, Yamauchi Y, Takeda N, Desrosiers M, et al. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy increases CD4+CD25+ T cells in the nasal mucosa of subjects with allergic rhinitis. Allergol Int 2008;57(4):377-81.
6. Nakajima H, Iwamoto I, Matsumura R, Tomioka H, Takatsu K, Yoshida S. CD4+T-lymphocytes and interleukin-5 mediated antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 1992; 146(2):374 -7.
7. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al. Predominant Th2-like bronchoalveolar T lymphocyte population in atopic asthma. N Engl J Med 1992; 326(5): 298 -304.
8. Nakajima H, Iwamoto I, Yoshida S. Aerosolized recombinant interferon- γ prevents antigen-induced eosinophil recruitment in mouse trachea. Am Rev Respir Dis 1993; 148(4 pt 1):1102- 4.
9. Sur S, Lam J, Bouchard P, Sigounas A, Holbert P, Metzger MJ. Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses. J Immunol 1996; 157(9):4173-80.
10. Busse W, Gross G, Korenblat P, Nayak N, Tarpay M, Levitt D. Phase 2/3 study of the novel vaccine amba 1 immunostimulatory oligodeoxyribonucleotide conjugate AIC in ragweed-allergic adults. J Allergy Clin Immunol 2006; 117:347.
11. Heeg K, Dalpke A, Peter M, Zimmermann S. Structural requirements for uptake and recognition of CpG oligonucleotides. Int J Med Microbiol 2008; 298(1-2):33-8.
12. Rezaei N. Therapeutic targeting of pattern- recognition receptors. Int Immunopharmacol 2006; 6(6):863-9.
13. Jurk M, Vollmer J. Therapeutic applications of synthetic CpG oligodeoxynucleotides as TLR9 agonists for immune modulation. BioDrugs 2007; 21(6):387-01.
14. Saikh KU, Kissner TL, Sultana A, Ruthel G, Ulrich RG.Human monocytes infected with Yersinia pestis express cell surface TLR9 and differentiate in to dendretetic cells. J Immunol 2004; 173(12):7426-43.
15. Jozsef L, Khreiss T, El Kebir D, Filep JG. Activation of TLR-9 induces IL-8 secretion through peroxynitrite signaling in human neutrophils. J Immunol 2006;176(2):1195-202.
16. Broide DH. Immunomodulation of Allergic Disease.Annu Rev Med 2009; 60:279-91.
17. Horner AA, Redecke V, Raz E. Toll-like receptor ligands: hygiene, atopy and therapeutic implications. Curr Opin Allergy Clin Immunol 2004; 4(6):555-61.
18. Krieg AM. Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov 2006; 5(6):471-84.
19. Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci USA 1996;93(7):2879-83.
20. Broide D, Schwarze H, Tighe H, Gifford T, Nguyen MD, Malek S, et al. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic ﬂianmmation, and airway hyperresponsiveness in mice. J Immunol 1998;161(12):7054-62.
21. Kline JN, Waldschmidt TJ, Businga TR, Lemish JE, Weinstock JV, Thorne PS, et al. Modulation of airway inﬂammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol 1998; 160(6):2555-9.
22. Sur S, Wild JS, Choudhury BK, Sur N, Alam R, Klinman DM. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J Immunol 1999; 162(12):6284-93.
23. Kohama Y, Akizuki O, Hagihara K, Yamada E, Yamamoto H. Immunostimulatory oligodeoxynucleotideinduces T immune response and inhibition of IgE antibody production to cedar pollen allergen in mice. J Allergy Clin Immunol 1999; 104(6):1231-8.
24. Hussain I, Jain VV, Kitagaki K, Businga TR, O'Shaughnessy P, Kline JN. Modulation of murine allergic rhinosinusitis by CpG oligodeoxynucleotides. Laryngoscope 2002; 112(10):1819-26.
25. Tulic MK, Fiset PO, Christodoulopoulos P, Vaillancourt P, Desrosiers M, Lavigne F, et al. Amb a 1- immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nﬂasaaml maitnory response. J Allergy Clin Immunol 2004; 113(2):235-41.
26. Marshall JD, Abtahi S, Eiden JJ, Tuck S, Milley R, Haycock F, et al. Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes Th1 cytokine expression while downregulating Th2 cytokine expression in PBMCs from human patients with ragweed allergy. J Allergy Clin Immunol 2001; 108(2):191-7.
27. Tighe H, Takabayashi K, Schwartz D, Van Nest G, Tuck S, Eiden JJ, et al. Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 2000; 106(1 pt 1):124-34.
28. Mousavi T, Salek Moghadam A, Falak R, Tebyanian M.Co-administration of CpG oligonucleotides and chenopodium album extract reverse IgG2a/IgG1 ratios and increase IFN-gamma and IL-10 productions in a murine model of asthma. Iran J Allergy Asthma Immunol 2008; 7(1):1-6.
29. Mousavi T, Salek Moghadam A, Falak R.Immunotherapy of Chenopodium album induced asthma by intranasal administration of CpG oligodeoxynucleotides in BALB/c mice. Iran J Immunol 2008; 5(1):57-63. 30. Mousavi T, Movahedi M, Asadi N, Farhoudi A, Moin M.The comparison of conventional and W.H.O. Methods for protein determination of chenopodium album allergenic extract. Iran J Allergy Asthma Immunol 2003; 2(2):107-9.
31. Mossmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65(1-2):55-63.
32. Liu N, Ohnishi N, Ni L, Akira S, Bacon KB. CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells. Nat Immunol 2003; 4(7):687-93.
33. Jones TR, Obaldia N, Gramzinski RA, Charoenvit Y, Kolodny N, Kitov S, et al. Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys. Vaccine 1999; 17(23-24):3065-71.
34. Walker PS, Scharton-Kersten T, Krieg AM, Love- Homan L, Rowton ED, Udey MC, et al. Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms. Proc Natl Acad Sci USA 1999;96(12):6970-5.
35. Wooldridge JE, Ballas Z, Krieg AM, Weiner GJ.Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma. Blood 1997; 89(8):2994-8.
36. Horner AA, Takabayashi K, Beck L, Sharma B, Zubeldia J, Baird S, et al. Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicity. J Allergy Clin Immunol 2002;110(3):413-20.
37. San Román B, Irache JM, Gómez S, Gamazo C, Espuelas S. Co-delivery of ovalbumin and CpG motifs into microparticles protected sensitized mice from anaphylaxis. Int Arch Allergy Immunol 2009;149(2):111-8.
38. Bauer M, Heeg K, Wagner H, Lipford GB. DNA activates human immune cells through a CpG sequence- dependent manner. Immunology 1999; 97(4):699-705.
39. Verthelyi D, Ishii KJ, Gursel M, Takeshita F, Klinman DM. Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. J Immunol 2001; 166(4):2372-7.
40. de Brito CA, Fusaro AE, Victor JR, Rigato PO, Goldoni AL, Muniz BP, et al. CpG-Induced Th1-Type Response in the Downmodulation of Early Development of Allergy and Inhibition of B7 Expression on T Cells of Newborn Mice. J Clin Immunol 2010; 30(2):280-91.
41. Klinman DM. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol 2004;4(4):249-58.
42. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, et al. Quantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002;168(9):4531-7.
43. Akdis CA, Blesken T, Akdis M, Wüthrich B, Blaser K.Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998; 102(1):98-106.

Files	XML PDF (348KB)
Issue	Vol 10, No 2 (2011)
Section	Articles
Keywords
Allergic Rhinitis CpG ODN Chenopodium album Cytokines Specific IgE

Rights and permissions
	This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

Farrokhi S, Mousavi T, Arshi S, Varasteh A, Rezaei N, Salekmoghadam A. Co-Administration of Chenopodium Album Allergens and CpG Oligodeoxy-nucleotides Effects on Peripheral Blood Mononuclear Cells of Patients with Allergic Rhinitis Treated with Intranasal Corticosteroids. Iran J Allergy Asthma Immunol. 1;10(2):101-110.

Vancouver

Download Citation